Shopping Cart
- Remove All
- Your shopping cart is currently empty
Loncastuximab (RB4v1.2), an anti-CD19 monoclonal antibody, exhibits antitumor properties and holds potential for treating non-Hodgkin's lymphoma (NHL), specifically diffuse large B-cell lymphoma (DLBCL) [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $290 | 2-4 weeks | |
5 mg | $755 | 2-4 weeks | |
10 mg | $1,200 | 2-4 weeks |
Description | Loncastuximab (RB4v1.2), an anti-CD19 monoclonal antibody, exhibits antitumor properties and holds potential for treating non-Hodgkin's lymphoma (NHL), specifically diffuse large B-cell lymphoma (DLBCL) [1] [2]. |
Cas No. | 1875032-68-0 |
Storage | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.